The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome

Summary

The objective of this study was to assess the efficacy of Botulinum toxin type (A) (BoNTA) injection in Myofascial pain syndrome management in the terms of duration of function improvement and pain reduction. Material and methods: Fourteen patients with Myofascial pain syndrome related to masticatory muscles were presented with trismus, pain and impairment of oral function. Treatment plan was established by utilizing thirty units of Botulinum toxin type (A) which was injected into masseter and sometimes temporalis muscle.

Timeline

Start

2024-03-12

Primary completion

2024-11-04

Completion

2025-01-06

Drugs

Indications